Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.84 is 81% above its 5-year average of -9.44, near the high end of its 5-year range (-41.18–11.21).
24.74% above its 12-month average of -2.44.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.63.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 31 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:58:57.474Z. Historical observations retain their original dates. Historical series through 2024-08-08.
EARNINGS PER SHARE (EPS)
-1.84
EARNINGS PER SHARE (EPS) AVG TTM
-2.44
EARNINGS PER SHARE (EPS) AVG 3Y
-1.37
EARNINGS PER SHARE (EPS) AVG 5Y
-9.44
EARNINGS PER SHARE (EPS) AVG 10Y
-51.94
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+24.74%
CURRENT VS 3Y AVG
-34.55%
CURRENT VS 5Y AVG
+80.50%
CURRENT VS 10Y AVG
+96.46%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SCYNEXIS, Inc.
Market Cap
$30.31M
Earnings Per Share (EPS)
-1.84
TTM Avg
-2.44
3Y Avg
-1.37
5Y Avg
-9.44
Market Cap
$30.43M
Earnings Per Share (EPS)
-1.39
TTM Avg
-0.88
3Y Avg
-6.06
5Y Avg
-17.91
Market Cap
$30.92M
Earnings Per Share (EPS)
-3.21
TTM Avg
-2.50
3Y Avg
-4.25
5Y Avg
-9.67
Market Cap
$29.04M
Earnings Per Share (EPS)
-0.17
TTM Avg
-0.24
3Y Avg
-0.47
5Y Avg
-0.92
Market Cap
$30.81M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.73
3Y Avg
-1.47
5Y Avg
-1.95
Market Cap
$29.74M
Earnings Per Share (EPS)
-1.38
TTM Avg
-0.93
3Y Avg
-0.75
5Y Avg
-0.52
Market Cap
$29.74M
Earnings Per Share (EPS)
-4.31
TTM Avg
-4.75
3Y Avg
-350.99
5Y Avg
-43000.60
Market Cap
$29.60M
Earnings Per Share (EPS)
-1.87
TTM Avg
-12.30
3Y Avg
-40.98
5Y Avg
-45.74
Market Cap
$29.57M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.42
3Y Avg
-0.82
5Y Avg
-1.14
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SCYNEXIS, Inc. (SCYX) | $30.31M | -1.84 | -2.44 | -1.37 | -9.44 |
| Rockwell Medical, Inc. (RMTI)vs › | $30.43M | -1.39 | -0.88 | -6.06 | -17.91 |
| CervoMed Inc. (CRVO)vs › | $30.92M | -3.21 | -2.50 | -4.25 | -9.67 |
| BeyondSpring Inc. (BYSI)vs › | $29.04M | -0.17 | -0.24 | -0.47 | -0.92 |
| MDxHealth S.A. (MDXH)vs › | $30.81M | N/A | -0.73 | -1.47 | -1.95 |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.74M | -1.38 | -0.93 | -0.75 | -0.52 |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | -4.31 | -4.75 | -350.99 | -43000.60 |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | -1.87 | -12.30 | -40.98 | -45.74 |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | -0.48 | -0.42 | -0.82 | -1.14 |
| Nortech Systems Incorporated (NSYS)vs › | $31.51M | 0.37 | -0.28 | 0.68 | 0.80 |
Trailing EPS (TTM)
$-1.84
Forward EPS (Est.)
$-2.91
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.38 |
| 2024-12-31 | -3.51 |
| 2023-12-31 | 11.21 |
| 2022-12-31 | -11.79 |
| 2021-12-31 | -9.97 |
| 2020-12-31 | -41.18 |
| 2019-12-31 | -76.62 |
| 2018-12-31 | -22.73 |
| 2017-12-31 | -75.20 |
| 2016-12-31 | -126.04 |
| 2015-12-31 | -214.08 |
| 2014-12-31 | -83.20 |
| 2012-12-31 | -580.80 |
